Amgen (AMGN) Receivables - Other (2013 - 2024)
Amgen (AMGN) posted quarterly Receivables - Other of $198.0 million for Q4 2024, down 60.56% year-over-year from $502.0 million in Q1 2024, and down 60.56% quarter-over-quarter from $502.0 million in Q4 2023.
Amgen (AMGN) Receivables - Other (2013 - 2024) Analysis & Trends
Amgen's Receivables - Other history runs 8 years deep, the most recent figure standing at $198.0 million for Q4 2024.
- In Q4 2024, Receivables - Other fell 60.56% year-over-year to $198.0 million; the TTM figure through Dec 2024 stood at $198.0 million (down 60.56% YoY), while the FY2024 annual figure was $198.0 million, down 60.56% from the prior year.
- Receivables - Other for Q4 2024 stood at $198.0 million, down from $502.0 million in the prior quarter.
- The five-year high for Receivables - Other was $700.0 million in Q4 2022, with the low at $164.0 million in Q4 2021.
- The 5-year median for Receivables - Other is $216.0 million (2020), against an average of $356.0 million.
- The sharpest annual moves came in 2022 and 2024: Receivables - Other surged 326.83% in 2022, then slumped 60.56% in 2024.
- Amgen's Receivables - Other stood at $216.0 million in 2020, then decreased by 24.07% to $164.0 million in 2021, then surged by 326.83% to $700.0 million in 2022, then retreated by 28.29% to $502.0 million in 2023, then plunged by 60.56% to $198.0 million in 2024.
- Business Quant data shows AMGN's Receivables - Other at $198.0 million in Q4 2024, $502.0 million in Q4 2023, and $700.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 198.00 Mn |
| Dec 31, 2024 | 198.00 Mn |
| Dec 31, 2023 | 502.00 Mn |
| Dec 31, 2023 | 502.00 Mn |
| Dec 31, 2022 | 700.00 Mn |
| Dec 31, 2022 | 700.00 Mn |
| Dec 31, 2021 | 164.00 Mn |
| Dec 31, 2021 | 164.00 Mn |
| Dec 31, 2020 | 216.00 Mn |
| Dec 31, 2020 | 216.00 Mn |
| Dec 31, 2019 | 186.00 Mn |
| Dec 31, 2019 | 186.00 Mn |
| Dec 31, 2018 | 444.00 Mn |
| Dec 31, 2018 | 444.00 Mn |
| Dec 31, 2013 | 22.00 Mn |
| Dec 31, 2013 | 22.00 Mn |